No Data
Express News | Warm Autoimmune Hemolytic Anemia (Waiha) Research Presented by Johnson & Johnson Highlights Profound Disease Burden and Unmet Need for Targeted Treatment Options
Johnson & Johnson Says 2 Studies of Potential Early Multiple Myeloma Drug Showed 'Promising' Efficacy
Johnson & Johnson Says Darzalex Faspro Shows Improved Outcomes in Multiple Myeloma Study
Express News | Reported Sunday, Johnson & Johnson Highlights TECVAYLI's Role In Advancing Frontline Multiple Myeloma Care With 100% MRD-Negative Results At ASH 2024
This AI Robot Trader Loves Tesla and Other Trump Trades
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.